Cure Today3d
The FDA Grants ODD to OPN-6602 For Relapsed/Refractory Myeloma
The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...
Psychology Today8d
Oppositional Defiance (ODD) Therapists in Nevada
Therapists Online Therapy Psychiatrists Treatment Centers Support Groups US Log In Sign Up and Get Listed Home Nevada NV Oppositional Defiance (ODD) Oppositional Defiance (ODD) Therapists in ...
Yahoo Finance29d
FDA grants ODD status to Zai Lab’s lung cancer treatment
"FDA grants ODD status to Zai Lab’s lung cancer treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...
PharmiWeb9d
Lundbeck’s potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...
News Medical on MSN11d
Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
GlobalData on MSN15d
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
A lingering question at Coinbase: Who really owns the customers’ crypto?
An odd thing happened when Coinbase reported its quarterly financial results last week. The bulk of its assets and ...
What Culture14h
10 Confusing Trends The Gaming Industry Is Convinced You Like
The industry is made up of people trying to turn their games into success stories, so trends and tropes are often adopted to ...
JENNI MURRAY: My biggest regret in life? Ignoring the letter offering a cancer scan
My surgeon gently chided me during my consultation. Had I had the mammogram when I was invited, a lumpectomy might have ...
Egetis Therapeutics AB: European Commission approves Egetis' Emcitate (tiratricol) as the first and only treatment for patients with MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...